Suppr超能文献

相似文献

1
Tumor immune microenvironment in head and neck cancers.
Mol Carcinog. 2020 Jul;59(7):766-774. doi: 10.1002/mc.23162. Epub 2020 Feb 3.
2
Head and neck cancer treatment in the era of molecular medicine.
Adv Cancer Res. 2023;160:205-252. doi: 10.1016/bs.acr.2023.03.004. Epub 2023 Apr 12.
3
Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma.
Int J Mol Sci. 2020 Sep 24;21(19):7032. doi: 10.3390/ijms21197032.
5
Immunotherapy for Head and Neck Cancer.
Hematol Oncol Clin North Am. 2019 Apr;33(2):301-321. doi: 10.1016/j.hoc.2018.12.006.
6
APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.
Oral Oncol. 2019 Sep;96:140-147. doi: 10.1016/j.oraloncology.2019.07.020. Epub 2019 Jul 30.
8
Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics.
Clin Cancer Res. 2019 Jul 15;25(14):4211-4223. doi: 10.1158/1078-0432.CCR-18-0871. Epub 2019 Feb 27.
9
Macrophages: plastic participants in the diagnosis and treatment of head and neck squamous cell carcinoma.
Front Immunol. 2024 Apr 8;15:1337129. doi: 10.3389/fimmu.2024.1337129. eCollection 2024.

引用本文的文献

1
Molecular Targets for Pharmacotherapy of Head and Neck Squamous Cell Carcinomas.
Curr Issues Mol Biol. 2025 Aug 1;47(8):609. doi: 10.3390/cimb47080609.
2
Construction and validation of an anoikis-related long non-coding RNA-based prognostic model for head and neck squamous cell carcinoma.
Transl Cancer Res. 2025 Jul 30;14(7):4160-4178. doi: 10.21037/tcr-2024-2520. Epub 2025 Jul 25.
6
7
Spatial Transcriptomic Landscape of Canine Oral Squamous Cell Carcinoma.
Mol Carcinog. 2025 Sep;64(9):1415-1428. doi: 10.1002/mc.23932. Epub 2025 Jun 17.
8
CBD promotes antitumor activity by modulating tumor immune microenvironment in HPV associated head and neck squamous cell carcinoma.
Front Immunol. 2025 May 22;16:1528520. doi: 10.3389/fimmu.2025.1528520. eCollection 2025.
9
Effect of deubiquitinases in head and neck squamous cell carcinoma (Review).
Oncol Lett. 2025 Apr 23;29(6):307. doi: 10.3892/ol.2025.15053. eCollection 2025 Jun.

本文引用的文献

1
Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy.
Transl Oncol. 2020 Feb;13(2):262-274. doi: 10.1016/j.tranon.2019.11.008. Epub 2019 Dec 21.
2
CAR T cell therapy: A new era for cancer treatment (Review).
Oncol Rep. 2019 Dec;42(6):2183-2195. doi: 10.3892/or.2019.7335. Epub 2019 Sep 24.
5
Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma.
Cancer Immunol Res. 2019 Oct;7(10):1700-1713. doi: 10.1158/2326-6066.CIR-18-0725. Epub 2019 Aug 6.
6
Clinical update on head and neck cancer: molecular biology and ongoing challenges.
Cell Death Dis. 2019 Jul 15;10(8):540. doi: 10.1038/s41419-019-1769-9.
7
The changing therapeutic landscape of head and neck cancer.
Nat Rev Clin Oncol. 2019 Nov;16(11):669-683. doi: 10.1038/s41571-019-0227-z. Epub 2019 Jun 12.
8
Macrophages Promote Growth of Squamous Cancer Independent of T cells.
J Dent Res. 2019 Jul;98(8):896-903. doi: 10.1177/0022034519854734. Epub 2019 Jun 12.
9
Interaction of tumor-associated macrophages and cancer chemotherapy.
Oncoimmunology. 2019 Apr 13;8(7):1596004. doi: 10.1080/2162402X.2019.1596004. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验